Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pain Mechanisms in Young Adolescent Females With Longstanding Patellofemoral Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03051412
Recruitment Status : Completed
First Posted : February 13, 2017
Last Update Posted : November 14, 2017
Sponsor:
Collaborator:
Research Unit of General Practice, Aalborg
Information provided by (Responsible Party):
Sinead Holden, Aalborg University

Brief Summary:

Patellofemoral pain (PFP) is a highly prevalent musculoskeletal condition in adult females, which is associated with decreased quality of life and physical activity levels. PFP is highly persistent, with up to 50% of adolescents reporting persistent pain at both one and two year follow-ups. Previous research has demonstrated altered pain sensitivity in in older individuals with chronic pain, however, less is known about this in conditions such as PFP, which is common in younger populations. Additionally it is unknown if these characteristics return to similar values as healthy controls, when symptoms resolve.

The aim of this study will be to compare pain sensitivity in individuals with PFP, compared to those with a previous history of PFP who currently are pain-free, and a control group with no history of knee pain.


Condition or disease Intervention/treatment
Patellofemoral Pain Syndrome Pain Other: No Intervention

Detailed Description:

Recently it has been demonstrated that females with longstanding PFP demonstrate increased pain sensitivity, or hyperalgesia in the peripheral nervous system and impaired conditioned pain modulation, which is representative of decreased descending control of pain in the central nervous system. This is commonly seen in older adults with chronic longstanding pain, such as knee OA.

Understanding the evolution of pain mechanisms during recovery may yield important insights into the highly recurrent nature of this condition. Self-reported recovery appears to be associated with increased pressure pain thresholds, in comparison to those with current PFP. However, it is unknown whether these characteristics, along with centrally mediated pain processing, ever return to 'normal', or to the same levels of those with no history of pain.

To examine this, the investigation will compare the three groups (PFP versus Recovered versus Control), on measures of pain sensitivity (as defined in the primary and secondary outcomes), to determine differences between groups.

Demographic data, regarding age, height and weight will be collected, as well as pain frequency (almost daily, several times per week, weekly, monthly, rarely, never), pain intensity (measured on numeric rating scale), Knee Injury and Osteoarthritis Outcome score, and spatial distribution of pain (using the Navigate pain application). The group that self report as recovered, will be asked to report when their symptoms resolved.

A subgroup analysis will be undertaken in the recovered group, to examine the relationship between the time since last knee pain was experienced, (duration they self- report being symptom-free), and pain sensitivity, as assessed by the primary and secondary outcome measures.

Participants will be recruited from the Adolescent Pain in Aalborg (APA2011) cohort. In 2011, a cohort of 2200 adolescents aged 15 to 19 years answered an online questionnaire on musculoskeletal pain. Of these, 504 reported knee pain, and 153 of these were clinically diagnosed with PFP. Five years later, the 504 adolescents, as well as 252 randomly selected adolescents who did not report knee pain in 2011, completed a follow-up questionnaire regarding current pain (clinical trials.gov identifier: NCT02873143). From this group, a sample of participants' who were diagnosed with PFP in 2011, and self report with current pain, or as 'recovered' will be randomly contacted for inclusion in the current investigation (PFP and recovered groups respectively). Additionally, of the control participants from the original APA2011 cohort, who reported no pain in 2011, and no pain in 2016, a random sample will be drawn and invited to participate as the control group.

If this cohort is insufficient to reach the required sample size (n = 36 in each group), participants will be recruited through other sources such as GP's, and social media.

Embedded within this cross-sectional study, is a randomized crossover trial (in the group with PFP) which has been approved by the local ethical committee under the same approval number (N-20160058). This can be accessed on clinicaltrials.gov under the title "The acute effects of hip and knee exercises on pain sensitivity in young adult females with long-standing patellofemoral pain - a randomized crossover study." with Dr. Michael Rathleff as the primary investigator.

Layout table for study information
Study Type : Observational
Actual Enrollment : 87 participants
Observational Model: Case-Control
Time Perspective: Cross-Sectional
Official Title: Differences in Pain Sensitivity in Young Females With Longstanding Patellofemoral Pain, Recovered Females With a History of PFP, and Healthy Controls.
Actual Study Start Date : February 22, 2017
Actual Primary Completion Date : August 31, 2017
Actual Study Completion Date : August 31, 2017

Group/Cohort Intervention/treatment
Current Patellofemoral Pain
This group has current patellofemoral pain
Other: No Intervention
No intervention

Recovered
This group has a previous history of patellofemoral pain, but currently self reports as recovered.
Other: No Intervention
No intervention

Control
This is a control group with no history of knee pain.
Other: No Intervention
No intervention




Primary Outcome Measures :
  1. Conditioned pain modulation [ Time Frame: Baseline ]
    Conditioned pain modulation (CPM) will be assessed using cuff algometry


Secondary Outcome Measures :
  1. Pressure pain thresholds will be measured around the lower leg and forearm [ Time Frame: baseline ]
    Mechanical pressure pain thresholds will be assessed using a handheld algometer to assess distal and remote hyperalgesia.

  2. Pressure Pain thresholds at the knee [ Time Frame: baseline ]
    Mechanical pressure pain thresholds will be assessed using a handheld algometer to assess local hyperalgesia.

  3. Temporal summation of pain [ Time Frame: baseline ]
    Temporal summation is be induced by 10 short-lasting stimuli (1 sec each) at the level of PTT given with a 1 sec break in between stimuli using the cuff algometry. Subject will be instructed to rate the pain intensity after each stimulus using an electronic VAS scale.

  4. Pressure detection & pressure tolerance threshold assessed by cuff algometry [ Time Frame: baseline ]
    Pressure detection & tolerance thresholds will be assessed bilaterally on the lower extremity using cuff algometer.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
The study population will consist of young females. One group will include participants with current longstanding patellofemoral pain, while a second group will include those with a history of pain, who self report as recovered, and a control group, who has no previous history of knee pain.
Criteria

Patellofemoral Pain Group:

Inclusion:

  • Female
  • Age 18-30years
  • Current longstanding patellofemoral pain

Exclusion Criteria:

  • Patients who have sustained a traumatic injury to the hip, knee, ankle or the lumbar spine within the past 3 month will be excluded.
  • Participants will be excluded if they have other diagnosable pathologies that can cause pain around the kneecap (patellatendinopathy, Osgood-Shlatter, iliotibial band syndrome, Sinding-Larsen-Johansson syndrome, reverse jumper) if they occur in isolation (without patellofemoral pain).

Recovered Group:

Inclusion:

  • Previous history of patellofemoral pain, reporting no current knee pain
  • Female
  • Aged 18-30 years

Exclusion:

  • Participants will be excluded if they have other diagnosable pathologies that can cause pain around the kneecap (patellatendinopathi, Osgood-Shlatter, iliotibial band syndrome, Sinding-Larsen-Johansson syndrome, reverse jumper)
  • Other pain conditions

Control:

Inclusion:

  • Female
  • Aged 18-30

Exclusion:

  • Current knee or other other musculoskeletal pain
  • Previous history of knee or musculoskeletal pain

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03051412


Locations
Layout table for location information
Denmark
Research Unit for General Practice in Aalborg
Aalborg, Denmark, 9000
Sponsors and Collaborators
Aalborg University
Research Unit of General Practice, Aalborg
Investigators
Layout table for investigator information
Principal Investigator: Sinead Holden, PhD Research Unit for General Practice, Department of Clinical Medicine, Aalborg University
Layout table for additonal information
Responsible Party: Sinead Holden, Post- Doctoral Research Fellow, Aalborg University
ClinicalTrials.gov Identifier: NCT03051412    
Other Study ID Numbers: N-20160058 (1)
First Posted: February 13, 2017    Key Record Dates
Last Update Posted: November 14, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Patellofemoral Pain Syndrome
Joint Diseases
Musculoskeletal Diseases